Biohaven Pharmaceutical Holding Co is a biotechnology business based in the US. Biohaven Pharmaceutical Holding Co shares (BHVN) are listed on the NYSE and all prices are listed in US Dollars.
How to buy Biohaven Pharmaceutical Holding Co stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – BHVN. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Biohaven Pharmaceutical Holding Co stock price (NYSE: BHVN)
Use our graph to track the performance of BHVN stocks over time.Biohaven Pharmaceutical Holding Co shares at a glance
Latest market close | $18.81 |
---|---|
52-week range | $5.54 - $20.00 |
50-day moving average | $15.48 |
200-day moving average | $14.08 |
Wall St. target price | $24.20 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-11.85 |
Buy Biohaven Pharmaceutical Holding Co stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Biohaven Pharmaceutical Holding Co stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Biohaven Pharmaceutical Holding Co price performance over time
Historical closes compared with the close of $18.81 from 2023-01-27
1 week (2023-01-20) | 2.01% |
---|---|
1 month (2022-12-29) | 30.90% |
3 months (2022-10-28) | 22.70% |
6 months (2022-07-29) | -87.12% |
1 year (2022-01-28) | -85.26% |
---|---|
2 years (2021-01-29) | -77.93% |
3 years (2020-01-29) | 50.9 |
5 years (2018-01-25) | N/A |
Biohaven Pharmaceutical Holding Co financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | 0% |
Return on equity TTM | 0% |
Profit margin | 0% |
Book value | $1.47 |
Market capitalisation | $1.3 billion |
TTM: trailing 12 months
Biohaven Pharmaceutical Holding Co share dividends
We're not expecting Biohaven Pharmaceutical Holding Co to pay a dividend over the next 12 months.
Biohaven Pharmaceutical Holding Co overview
Biohaven Ltd. , a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases in the United States. The company's pipeline products include BHV-7000, a potassium channel activator for the treatment of focal epilepsy; Troriluzole, a tripeptide prodrug that is in Phase 3 clinical trial for the treatment of neurological and neuropsychiatric illnesses; BHV-5500, a low-trapping glutamate N-methyl-D-aspartate receptor antagonist for neuropathic pain; and Verdiperstat, an irreversible myeloperoxidase enzyme inhibitor for the treatment of neurodegenerative diseases. It also offers Taldefgrobep Alfa, an anti-myostatin adnectin, which is in Phase 3 clinical trial to treat spinal muscle atrophy; and BHV-1100 that is in Phase 1a/1b clinical trial for multiple myeloma patients. The company was formerly known as Biohaven Research Ltd and changed its name to Biohaven Ltd. in Sept 2022. The company was incorporated in 2022 and is headquartered in New Haven, Connecticut.
Biohaven Pharmaceutical Holding Co in the news
Biohaven to Present at the 41st Annual J.P. Morgan Healthcare Conference
Looking for Hidden Gems? J.P. Morgan Predicts Over 60% Gains for These 2 Stocks
Is Biohaven Ltd. (BHVN) Outperforming Other Medical Stocks This Year?
Frequently asked questions
What percentage of Biohaven Pharmaceutical Holding Co is owned by insiders or institutions?Currently 14.669% of Biohaven Pharmaceutical Holding Co shares are held by insiders and 38.134% by institutions. When does the fiscal year end for Biohaven Pharmaceutical Holding Co?
Biohaven Pharmaceutical Holding Co's fiscal year ends in December. Where is Biohaven Pharmaceutical Holding Co based?
Biohaven Pharmaceutical Holding Co's address is: 215 Church Street, New Haven, CT, United States, 06510
More guides on Finder
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert